GenieUs Genomics

📍 Darlinghurst, Australia👥 17 employees💰 Last funded Aug 2021
Biotechnology🌐 genieus.co
Website LinkedIn
At GenieUs, we recognize ALS as a pressing challenge with a high societal cost. With over 70% of ALS patients lacking a known molecular basis, our mission is to unveil the mysteries of this complex disease. We leverage cutting-edge genomics to provide robust in silico genetic understanding through our groundbreaking platform, the Deep integrated Genomic Analysis Platform - DiGAP™. 🔬 This depth of patient genomic profiling will create valuable opportunities for the biopharma industry to develop precision diagnostic and therapeutic solutions for ALS patients. 🌟 The DiGAP™ Deep Insight Report will provide clinicians with valuable insights to guide their therapeutic decisions. 🌐 GenieUs is uniquely positioned to transform the ALS landscape. We're not just pioneers; we're strategists ready to capitalize on the commercial potential of our innovative solutions. Our commitment is to reshape the narrative around ALS and make a lasting impact on patient lives.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Norway
1
Frequently asked questions
Who invested in GenieUs Genomics?
GenieUs Genomics has 1 investors on record on gritt.io.
When did GenieUs Genomics last raise funding?
The most recent investment in GenieUs Genomics recorded on gritt.io was in August 2021.
What industry is GenieUs Genomics in?
GenieUs Genomics operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is GenieUs Genomics based?
GenieUs Genomics is headquartered in Darlinghurst, Australia.